UnicoCell Biomed , Ltd. PEG Ratio

The latest PEG ratio for 6794.TW is -42.14. That is below the Healthcare sector average of 11.77. Investors often review this figure alongside UnicoCell Biomed , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, 6794.TW currently prints -42.14 for PEG ratio, while the sector average sits near 11.77. That is roughly 458.0% below the sector mean. Large gaps often invite a closer look at UnicoCell Biomed , Ltd.'s growth, margins, and balance sheet.

A PEG ratio of -42.14 for UnicoCell Biomed , Ltd. is not 'good' or 'bad' on its own. Compare it with the peer average (11.77) and with 6794.TW's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting 6794.TW's PEG ratio (-42.14), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack UnicoCell Biomed , Ltd.'s PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.